vTv Therapeutics (VTVT) Assets Average (2015 - 2026)

vTv Therapeutics has disclosed Assets Average across 12 years of filings, most recently posting $93.2 million for Q2 2026.

• In Q2 2026, Assets Average rose 218.78% year-over-year to $93.2 million; the TTM figure through Jun 2026 stood at $93.2 million (up 218.78% YoY), while the FY2025 annual figure was $64.1 million, up 160.05% from the prior year.
• Assets Average came in at $93.2 million for Q2 2026 at vTv Therapeutics, down from $94.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $94.7 million in Q4 2025 to a low of $13.0 million in Q4 2023.
• Average Assets Average over 5 years is $43.8 million, with a median of $34.8 million recorded in 2022.
• Year-over-year, Assets Average plunged 62.27% in 2023 and surged 218.78% in 2026.
• Over 5 years, Assets Average stood at $34.4 million in 2022, then sank by 62.27% to $13.0 million in 2023, then surged by 213.89% to $40.7 million in 2024, then jumped by 132.58% to $94.7 million in 2025, then retreated by 1.58% to $93.2 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $93.2 million in Q2 2026, $94.4 million in Q1 2026, and $94.7 million in Q4 2025.